IndraLab

Statements


USP47 inhibits KRAS inhibitor. 1 / 1
| 1

reach
"Targeting USP47 enhances the efficacy of KRAS inhibitor in KRASG12C mutated non-small cell lung cancer by controlling deubiquitination of c-Myc."